Inessa Advanced Daily Biotic

Inessa Advanced Daily Biotic

Regular price £35.00 Sale price £19.99

WHAT IS INESSA ADVANCED DAILY BIOTIC?

Inessa Advanced Daily Biotic provides Lactobacillus Rhamnosus GG, the most scientifically studied and best clinically documented strain of good bacteria in the world. Our evidence-based strain of bacteria guarantees you the highest quality in advanced delayed-release capsules proven to improve probiotic survival and delivery. Our clinical strength probiotic product delivers 10 Billion live CFU (colony-forming units) guaranteed to expiry date of Lactobacillus Rhamnosus GG, which is the #1 selling probiotic strain in the USA.

Each capsule typically contains

Lactobacillus Rhamnosus GG 10 billion CFU*
Glutamine 100mg


*Colony Forming Units (potency guaranteed to expiry date)

Ingredients

L-Glutamine, Capsule Shell (Hydroxy Propyl Methyl Cellulose, Gellan Gum), Lactobacillus rhamnosus GG (maltodextrin, L.rhamnosus GG), Silicon Dioxide, Stearic Acid


Best studied strain

Best studied strain

Provides the GG strain of Lactobacillus rhamnosus which is by far one of the most scientifically studied strains of good bacteria.1 There are more than 760 scientific publications and more than 260 clinical studies on Lactobacillus Rhamnosus GG.

Different strains of bacteria can have very different health effects even if they are the same genus or species.2 Accordingly, the strain identification can help you choose a product that provides bacteria that has been shown to have a probiotic effect (survive digestion and improve your gut bacteria) or a health benefit. Lactobacillus rhamnosus GG  is unique and has well documented effects.3


Evidence-based dose

Evidence-based dose

Provides 10 billion live bacteria in each vegan delayed-release capsule, which corresponds with the daily dose used in clinical studies of Lactobacillus rhamnosus GG.4 5 6 7 Using a clinically proven strain at a documented dose is more important than using multiple strains at a higher dose, in other words; more is not better.8


Delayed-release

Delayed-release

Clinically studies have shown that Lactobacillus rhamnosus GG delivery is improved with delayed-relapse capsules. Stomach acid can destroy bacteria and reduce their ability to reach the digestive system.9 Although Lactobacillus rhamnosus GG has good acid resistance, delayed-release capsules have been shown to improve survival and result in a lower dose requirement.10


No prebiotics

No prebiotics

For people avoiding prebiotic fibres, especially those on the special diets such as low-FODMAP (Fermentable, Oligo-, Di-, Mono-saccharides and Polyols) or SCD (Specific Carbohydrate Diet). Instead we use glutamine, a pure amino acid that complements the good bacteria.11 


For daily use

For daily use

Lactobacillus rhamnosus GG is perfect for everyday use to support general health and wellbeing. There are also several unique clinical uses associated with this special strain of good bacteria which may be recommended by your gastroenterologist or health care provider.

 


  1. Pace F, Pace M, Quartarone G. Probiotics in digestive diseases: focus on Lactobacillus GG. Minerva Gastroenterol Dietol. 2015 Dec;61(4):273-92
  2. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14.
  3. Segers ME, Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG--host interactions. Microb Cell Fact. 2014 Aug 29;13 Suppl 1:S7.
  4. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus  rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015 Nov;42(10):1149-57.
  5. Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema. Curr Opin Allergy Clin Immunol. 2013 Jun;13(3):280-6.
  6. Liu S, Hu P, Du X, Zhou T, Pei X. Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: a meta analysis of randomized, placebo-controlled trials. Indian Pediatr. 2013 Apr;50(4):377-81.
  7. Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children--updated analysis of randomised controlled trials. Aliment Pharmacol Ther. 2013 Sep;38(5):467-76.
  8. Sanders, ME. How Do We Know When Something Called “Probiotic” Is Really a Probiotic? A Guideline for Consumers and Health Care Professionals. Functional Food Reviews, Vol 1, No 1 (Spring), 2009: pp 3–12
  9. Sanders ME, Klaenhammer TR, Ouwehand AC, et al. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N Y Acad Sci. 2014 Feb;1309:1-18.
  10. Saxelin, M., M. Ahokas & S. Salminen. 1993. Dose response on the fecal colonisation of Lactobacillus strain GG administered in two different formulations. Microbial Ecol Health Dis 6: 119–122.
  11. de Souza AZ, Zambom AZ, et al. Oral supplementation with L-glutamine alters gut microbiota of obese and overweight adults: A pilot study. Nutrition. 2015;31(6):884-889.